G. Corsi, G. Palazzo, 1-Halobenzyl-1H-indazole-3-carboxylic acids. A new class of antispermatogenic agents., in J Med Chem, vol. 19, n. 6, giugno 1976, pp. 778-83, PMID950645.
TJ. Lobl, 1-(2,4-dichlorobenzyl)-1H-indazole-3-carboxylic acid (DICA), an exfoliative antispermatogenic agent in the rat., in Arch Androl, vol. 2, n. 4, giugno 1979, pp. 353-63, PMID496513.
A. Caputo, B. Silvestrini, Lonidamine, a new approach to cancer therapy., in Oncology, 41 Suppl 1, 1984, pp. 2-6, PMID6371644.
A. Floridi, A. Delpino; A. Nista; R. Feriozzi; ML. Marcante; B. Silvestrini; A. Caputo, Effect of lonidamine on protein synthesis in neoplastic cells., in Exp Mol Pathol, vol. 42, n. 3, giugno 1985, pp. 293-305, PMID3996552.
B. Silvestrini, G. Palazzo; M. De Gregorio, Lonidamine and related compounds., in Prog Med Chem, vol. 21, 1984, pp. 110-35, PMID6400133.
V. Cioli, C. Corradino; C. De Martino; P. Pasquini; V. Rossi; B. Silvestrini, Pharmacological investigations on lonidamine., in Arzneimittelforschung, vol. 34, n. 4, 1984, pp. 455-60, PMID6540104.
G. Segre, B. Catanese, Pharmacokinetics of lonidamine., in Chemotherapy, 27 Suppl 2, 1981, pp. 77-84, PMID7285639.
U. Gatzemeier, H. Toomes; R. Picollo; V. Christoffel; PW. Lücker; J. Ulmer, Single- and multiple dose pharmacokinetics of lonidamine in patients suffering from non-small-cell lung cancer., in Arzneimittelforschung, vol. 41, n. 4, Apr 1991, pp. 436-9, PMID1650226.
R. Heywood, RW. James; PS. Barcellona; A. Campana; V. Cioli, Toxicological studies on 1-substituted-indazole-3-carboxylic acids., in Chemotherapy, 27 Suppl 2, 1981, pp. 91-7, PMID7285641.
B. Silvestrini, GM. Hahn; V. Cioli; C. De Martino, Effects of lonidamine alone or combined with hyperthermia in some experimental cell and tumour systems., in Br J Cancer, vol. 47, n. 2, Feb 1983, pp. 221-31, PMID6824568.
N. Murray, A. Shah; P. Band, Phase II study of lonidamine in patients with small cell carcinoma of the lung., in Cancer Treat Rep, vol. 71, n. 12, Dec 1987, pp. 1283-4, PMID2825992.
A. Contu, NA. Olmeo; P. Pani; A. Deriu; S. Ortu; C. Paga, Lonidamine in non-small-cell lung cancer: a phase II study., in Tumori, vol. 77, n. 1, Feb 1991, pp. 52-5, PMID1850177.
PR. Band, J. Maroun; K. Pritchard; D. Stewart; CM. Coppin; K. Wilson; EA. Eisenhauer, Phase II study of lonidamine in patients with metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group Study., in Cancer Treat Rep, vol. 70, n. 11, Nov 1986, pp. 1305-10, PMID3768873.
P. Pronzato, D. Amoroso; G. Bertelli; PF. Conte; MP. Cusimano; GB. Ciottoli; M. Gulisano; R. Lionetto; R. Rosso, Phase II study of lonidamine in metastatic breast cancer., in Br J Cancer, vol. 59, n. 2, Feb 1989, pp. 251-3, PMID2930690.
R. Passalacqua, G. Bisagni; M. Bertusi; D. Donati; F. Buzzi; F. Di Costanzo; C. Basurto; S. Gori, Lonidamine in advanced colorectal cancer: a phase II study of the Italian Oncology Group for Clinical Research (GOIRC)., in Tumori, vol. 75, n. 3, Jun 1989, pp. 277-9, PMID2672481.
BH. Weinerman, EA. Eisenhauer; JG. Besner; CM. Coppin; D. Stewart; PR. Band, Phase II study of lonidamine in patients with metastatic renal cell carcinoma: a National Cancer Institute of Canada Clinical Trials Group Study., in Cancer Treat Rep, vol. 70, n. 6, Jun 1986, pp. 751-4, PMID3524824.